Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis

Annals of Allergy, Asthma and Immunology

Volumn 93, Issue 5, 2004, Pages 425-430

  Bowen, Tom ^a   Greenbaum, Joseph ^b   Charbonneau, Yves ^c   Hebert, Jacques ^d   Filderman, Ronald ^c   Sussman, Gordon ^c   Del Carpio, Jaime ^e   Gold, Milton ^c   Keith, Paul ^a   Moote, William ^f   Cecchetto, Steve ^g   Cecchetto, Ollie ^g   Sharp, Daniel ^g   Broutin, Olivier ^h   André, Claude ^h  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Laval University ^*

^d UNIVERSITÉ LAVAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g W Allerg Serv/Quorum Pharmaceut   (Canada)

^h Stallergenes SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; PLANT EXTRACT; RAGWEED ANTIGEN; STALORAL;

ADOLESCENT; ADULT; ARTICLE; CANADA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; NASAL PRURITUS; NAUSEA; POLLEN; PRIORITY JOURNAL; PRURITUS; RAGWEED; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SEASONAL VARIATION; SIDE EFFECT; SNEEZING; THROAT DISEASE; TONGUE DISEASE;

EID: 8644238187     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61408-1     Document Type: Article

References (20)

1. Noon L, Cantab BC. Prophylactic inoculation against hay fever. Lancet. 1911;i:1572-1573.
2. Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy. 1998;53:461-472.
3. Bousquet J, Lockey RF, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases (WHO position paper). Allergy. 1998;53(Suppl):1-42.
4. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol. 2003;111:437-448.
5. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 2003;issue 3.
6. Malling HJ. Is sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol. 2002;2:523-531.
7. Passalacqua G, Fumagalli F, Guerra L, Canonica GW. Safety of allergen-specific sublingual immunotherapy and nasal immunotherapy. Chem Immunol Allergy. 2003;82:109-118.
8. Andre C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol. 2000;121:229-234.
9. Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy. 2003;33:206-210.
10. Sabbah A, Hassoun S, Le Sellin J, Andre C, Sicard H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy. 1994;49:309-313.
11. Feliziani V, Lattuada G, Parmiani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts: a double blind study. Allergol Immunopathol Madr. 1995;23:224-230.
12. Purello-D'Ambrosio F, Gangemi S, Isola S, et al. Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both. Allergy. 1999;54:968-973.
13. Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy. 2000;55:842-849.
14. Cafferelli C, Sensi LG, Marcucci F, Cavagni G. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy. 2000;55:1142-1147.
15. Ariano R, Spadolini I, Panzani RC. Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica: a double blind study. Allergol Immunopathol Madr. 2001;29:238-244.
16. Andre C, Perrin-Fayolle M, Grosclaude M, et al. A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standardized ragweed extract in patients with seasonal rhinitis: evidence for a dose-response relationship. Int Arch Allergy Immunol. 2003;131:111-118.
17. Litwin A, Flanagan M, Entis G, et al. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy. Ann Allergy Asthma Immunol. 1996;77:132-138.
18. Van Deusen MA, Angelini BL, Cordoro KM, Seiler BA, Wood L, Skoner DP. Efficacy and safety of oral immunotherapy with short ragweed extract. Ann Allergy Asthma Immunol. 1997;78: 573-580.
19. Litwin A, Flanagan M, Entis G, et al. Oral immunotherapy with short ragweed extract in a novel encapsulated preparation: a double-blind study. J Allergy Clin Immunol. 1997;100:30-38.
20. Vervloet D, Birnbaum J, Laurent P, et al. Safety and clinical efficacy of rush sublingual Cyprus immunotherapy: preliminary results. Allergy. 2002;(Suppl 3):70.